Similarly to MDSCs, TAM have been reported to be sensitive to the Class I HDAC inhibitor VPA and the panHDAC inhibitor TSA, resulting in restoration of MHC class II expression, reversal of immune suppression and delayed tumor growth[123, 124]. The gene discussed is HDAC9; the disease is neoplasm.